Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA polymerase II (Pol II) is a prokaryotic DNA-dependent DNA polymerase primarily involved in DNA repair and acts as a backup enzyme for the main replicative polymerase, DNA polymerase III, in *Escherichia coli*. It catalyzes phosphodiester bond formation between nucleotides during both normal replication (as backup) and repair synthesis. It possesses 5'→3' polymerase activity and 3'→5' exonuclease (proofreading) activity. Its processivity is enhanced by interaction with accessory proteins such as the β-clamp and clamp loader complex.
Inhibition of DNA synthesis through competitive or non-competitive mechanisms
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Polymerase II (None).